The Hospital of the University of Pennsylvania is the flagship hospital of Penn Medicine and is located in the University City section of West Philadelphia. It is consistently ranked as one of the top hospitals in the United States.

There are 776 beds in Hospital of the University of Pennsylvania.

During the past decade, Hospital of the University of Pennsylvania conducted 365 clinical trials. In the 10-year time frame, 365 clinical trials started and 226 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 120 clinical trials started and 96 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital of the University of Pennsylvania" #1 sponsor was "University of Pennsylvania" with 172 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 58 trials sponsored, "Abbott Medical Devices" with 31 trials sponsored, "Gilead Sciences" with 18 trials sponsored and "AIDS Clinical Trials Group" with 18 trials sponsored. Other sponsors include 549 different institutions and companies that sponsored additional 317 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital of the University of Pennsylvania" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 24 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 22 trials as a collaborator, "University of Pennsylvania" with 21 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 16 trials as a collaborator. Other collaborators include 571 different institutions and companies that were collaborators in the rest 342 trials.

According to Clinical.Site data, the most researched conditions in "Hospital of the University of Pennsylvania" are "HIV Infections" (64 trials), "Heart Failure" (34 trials), "Stroke" (23 trials), "Atrial Fibrillation" (22 trials) and "HIV-1 Infection" (10 trials). Many other conditions were trialed in "Hospital of the University of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Hospital of the University of Pennsylvania" are "Drug" (427 trials), "Device" (233 trials), "Other" (86 trials), "Biological" (61 trials) and "Procedure" (54 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (81 trials), "Zidovudine" (12 trials), "Didanosine" (9 trials), "Lamivudine" (9 trials) and "Stavudine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hospital of the University of Pennsylvania" are 737 trials for "All" genders, 98 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital of the University of Pennsylvania". undefined are not yet recruiting, 104 are recruiting, 99 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 501 completed trials in Hospital of the University of Pennsylvania, undefined suspended trials, and 93 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital of the University of Pennsylvania, 101 "Phase 1" clinical trials were conducted, 212 "Phase 2" clinical trials and 182 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 225 trials that are defined as “Not Applicable".

Hospital of the University of Pennsylvania has several departments that took part in Clinical trials: "Abramson Cancer Center of the University of Pennsylvania" - 927 trials, "Joan Karnell Cancer Center at Pennsylvania Hospital" - 27 trials, "University of Pennsylvania, Department of Neurology" - 7 trials, "University of Pennsylvania, Department of Dermatology" - 5 trials, "Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program" - 4 trials, "University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine" - 3 trials, "Hospital of the University of Pennsylvania - Infectious Diseases" - 3 trials, "ALS Center at Penn" - 2 trials, "Radiant Research Philadelphia" - 2 trials, "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology" - 2 trials, "The Trauma Center at PENN" - 2 trials, "Penn Reproductive Research Unit, 3701 Market Street, Suite 810" - 2 trials, "Penn Orthopaedics" - 2 trials, "University of Pennsylvania, Department of Neurosurgery" - 2 trials, "Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania" - 2 trials